Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. The firm's lead candidates, Melphalan Hydrochloride for Injection and the Delcath Hepatic Delivery System are designed to administer high-dose chemotherapy to the liver while controlling side effects. The company was founded in 1988 and is based in Queensbury, NY.
What is Delcath Systems's quote symbol?
What is the 52 week high and low for Delcath Systems (NASDAQ: DCTH)?
How much is Delcath Systems stock worth today?
How much is Delcath Systems's stock price per share?
What is Delcath Systems's Market Cap?